Moreover, it is obvious that low-dose combined recombinant porcine IFN (105 U/kg) can significantly upregulate cytokines, significantly reduce virus output, inhibit ASFV proliferation, and alleviate the clinical signs of early infection. The gene discussed is IFNA1; the disease is infection.